nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Proteinuria—Sorafenib—liver cancer	0.0356	0.0356	CcSEcCtD
Lincomycin—Protein urine present—Sorafenib—liver cancer	0.0351	0.0351	CcSEcCtD
Lincomycin—Glossitis—Sorafenib—liver cancer	0.0339	0.0339	CcSEcCtD
Lincomycin—Hepatic function abnormal—Sorafenib—liver cancer	0.026	0.026	CcSEcCtD
Lincomycin—Anorectal discomfort—Epirubicin—liver cancer	0.0211	0.0211	CcSEcCtD
Lincomycin—Local reaction—Epirubicin—liver cancer	0.0209	0.0209	CcSEcCtD
Lincomycin—Vesiculobullous rash—Epirubicin—liver cancer	0.0206	0.0206	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—liver cancer	0.0196	0.0196	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—liver cancer	0.0193	0.0193	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—liver cancer	0.0191	0.0191	CcSEcCtD
Lincomycin—Abdominal discomfort—Sorafenib—liver cancer	0.0188	0.0188	CcSEcCtD
Lincomycin—Neutropenia—Sorafenib—liver cancer	0.0183	0.0183	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.0173	0.0173	CcSEcCtD
Lincomycin—Stomatitis—Sorafenib—liver cancer	0.0171	0.0171	CcSEcCtD
Lincomycin—Jaundice—Sorafenib—liver cancer	0.0171	0.0171	CcSEcCtD
Lincomycin—Erythema multiforme—Sorafenib—liver cancer	0.0148	0.0148	CcSEcCtD
Lincomycin—Tinnitus—Sorafenib—liver cancer	0.0146	0.0146	CcSEcCtD
Lincomycin—Abscess—Epirubicin—liver cancer	0.0146	0.0146	CcSEcCtD
Lincomycin—Rash pustular—Epirubicin—liver cancer	0.0145	0.0145	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—liver cancer	0.0135	0.0135	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—liver cancer	0.0134	0.0134	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—liver cancer	0.0125	0.0125	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—liver cancer	0.0125	0.0125	CcSEcCtD
Lincomycin—Angioedema—Sorafenib—liver cancer	0.0125	0.0125	CcSEcCtD
Lincomycin—Leukopenia—Sorafenib—liver cancer	0.0122	0.0122	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—liver cancer	0.0116	0.0116	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—liver cancer	0.0116	0.0116	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—liver cancer	0.0116	0.0116	CcSEcCtD
Lincomycin—Anaphylactic shock—Sorafenib—liver cancer	0.0112	0.0112	CcSEcCtD
Lincomycin—Colitis—Epirubicin—liver cancer	0.0111	0.0111	CcSEcCtD
Lincomycin—Shock—Sorafenib—liver cancer	0.011	0.011	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—liver cancer	0.0109	0.0109	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—liver cancer	0.0109	0.0109	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—liver cancer	0.0107	0.0107	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—liver cancer	0.0106	0.0106	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—liver cancer	0.0103	0.0103	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—liver cancer	0.0101	0.0101	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—liver cancer	0.01	0.01	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—liver cancer	0.00977	0.00977	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—liver cancer	0.00974	0.00974	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—liver cancer	0.00969	0.00969	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—liver cancer	0.0096	0.0096	CcSEcCtD
Lincomycin—Pain—Sorafenib—liver cancer	0.00954	0.00954	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—liver cancer	0.00901	0.00901	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—liver cancer	0.00897	0.00897	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—liver cancer	0.00888	0.00888	CcSEcCtD
Lincomycin—Urticaria—Sorafenib—liver cancer	0.00886	0.00886	CcSEcCtD
Lincomycin—Abdominal pain—Sorafenib—liver cancer	0.00882	0.00882	CcSEcCtD
Lincomycin—Body temperature increased—Sorafenib—liver cancer	0.00882	0.00882	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—liver cancer	0.00878	0.00878	CcSEcCtD
Lincomycin—Hypersensitivity—Sorafenib—liver cancer	0.00822	0.00822	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—liver cancer	0.00812	0.00812	CcSEcCtD
Lincomycin—Pruritus—Sorafenib—liver cancer	0.00789	0.00789	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—liver cancer	0.00775	0.00775	CcSEcCtD
Lincomycin—Diarrhoea—Sorafenib—liver cancer	0.00763	0.00763	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—liver cancer	0.00717	0.00717	CcSEcCtD
Lincomycin—Vomiting—Sorafenib—liver cancer	0.00709	0.00709	CcSEcCtD
Lincomycin—Rash—Sorafenib—liver cancer	0.00703	0.00703	CcSEcCtD
Lincomycin—Dermatitis—Sorafenib—liver cancer	0.00703	0.00703	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—liver cancer	0.00689	0.00689	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—liver cancer	0.00678	0.00678	CcSEcCtD
Lincomycin—Nausea—Sorafenib—liver cancer	0.00663	0.00663	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00641	0.00641	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—liver cancer	0.00637	0.00637	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—liver cancer	0.0063	0.0063	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—liver cancer	0.0063	0.0063	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—liver cancer	0.00627	0.00627	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—liver cancer	0.00603	0.00603	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00593	0.00593	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—liver cancer	0.00583	0.00583	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—liver cancer	0.00583	0.00583	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—liver cancer	0.00558	0.00558	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—liver cancer	0.00549	0.00549	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—liver cancer	0.00541	0.00541	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—liver cancer	0.00508	0.00508	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—liver cancer	0.00501	0.00501	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—liver cancer	0.00454	0.00454	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—liver cancer	0.00452	0.00452	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—liver cancer	0.0042	0.0042	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—liver cancer	0.00418	0.00418	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—liver cancer	0.00412	0.00412	CcSEcCtD
Lincomycin—Shock—Epirubicin—liver cancer	0.00406	0.00406	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—liver cancer	0.00382	0.00382	CcSEcCtD
Lincomycin—Shock—Doxorubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Lincomycin—Pain—Epirubicin—liver cancer	0.00353	0.00353	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Lincomycin—Pain—Doxorubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—liver cancer	0.00304	0.00304	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—liver cancer	0.00302	0.00302	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—liver cancer	0.00302	0.00302	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—liver cancer	0.00281	0.00281	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Lincomycin—Rash—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Lincomycin—Nausea—Epirubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Lincomycin—Rash—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—liver cancer	0.00227	0.00227	CcSEcCtD
